Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral nutrition (TPN), which is associated with significant toxicities; PS reduction ...

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

LAKE ZURICH, IL, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- The Sikh community in the United States, estimated ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...

Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new treatments, improve patient outcomes, and advance public health. Yet, the ...

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.

PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...